WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 15-Jul-2015 (Data received as of 10-Jul-2015)
Next overall update Fall 2015
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 6'0401 Infant (under 12 months) mortality rate: 202
GDP / capita (US$): 11'2931 Child (under 5 years) mortality rate: 232

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 15'983  15'738  15'492  15'246  15'001  12'533  10'124  7'909 
Births 328  328  328  327  327  318  304  275 
Surviving infants 322  322  322  321  321  309  289  254 
Pop. less than 5 years 1'604  1'599  1'594  1'591  1'592  1'503  1'407  1'218 
Pop. less than 15 years 4'734  4'715  4'691  4'667  4'643  4'329  3'863  3'304 
Female 15-49 years 4'174  4'115  4'054  3'991  3'927  3'245  2'504  1'835 

Number of reported case

(Click for retrospective incidence data for Ecuador)
Diphtheria 16 
Japanese encephalitis
Measles 72  263  1'646  2'722 
Mumps 1'522  1'308  799  733  1'331 
Pertussis 35  54  482  487  836 
Polio* 11 
Rubella 538 
Rubella (CRS)
Tetanus (neonatal) 88  28 
Tetanus (total)** 27  28  169  81 
Yellow fever 12 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Ecuador)
Vaccine year result method % card seen                                                
BCG 2011  98     88  89  90  99*  99*  99*  99*  99  75 
DTP1          84  87  99*  99*  99*  99* 
DTP3 2011  88     88  83  87  99*  99*  99*  88  75  10 
DTP4          70 
IPV1         
HepB_BD          79  69  16  40 
HepB3          83  87  99*  99*  99*  40 
Hib3          83  87  99*  99*  99* 
JapEnc         
MCV1          70  97  99*  94  99*  84  67  24 
MCV2          85  83  55  92  91 
PCV1          83  86  99*  99*  86 
PCV3          99*  90  94  71  17 
Pol3 2011  85     88  84  87  99*  99*  99*  84  77  19 
Rota1          84  85  99*  99*  99* 
Rota_last          81  83  99*  99*  99* 
Rubella1          70  97  99*  94  99* 
TT2plus 1988  48  MCH     54  64  75  75  70  31 
PAB         
VAD1          84 
YFV          86  73  89  89  96  28 
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Ecuador)
BCG 89  90  94  98  98  99  89  76 
DTP1 84  87  88  89  91  94  87  31 
DTP3 83  87  87  88  91  87  68  10 
HepB3 83  87  88  88  90  36 
HepB_BD 79  69  16 
Hib3 83  87  87  88  90 
MCV1 85  97  96  94  95  99  60  24 
MCV2 59  70  81  92  91 
PAB 85  85  85  85  74  42  82 
PCV3 90  90  94  71  17 
Pol3 84  87  85  85  88  83  67  19 
Rota_last 81  83  87  90  94 
YFV 86  73  74  74  81 

Number of districts in the country 221  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 25
From 80 to 89% 27
From 50 to 79% 45
Less than 50% 3
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 5 years; Yes
DTwP 18 months; Yes
DTwPHibHepB 2, 4, 6 months; Yes
HPV 9 years (x2); Yes
HepB_Adult No risk groups
HepB_Pediatric birth; Yes
Influenza_Adult >= 60 years; Yes and adults with chronic diseases, pregnant women, health care workers
Influenza_Pediatric 6 months to 4 years; Yes and children with chronic diseases
MMR 1, 6 years; Yes
MR 6 months; Yes
OPV 2, 4, 6, 18 months; Yes
Pneumo_conj 2, 4, 6 months; Yes
Pneumo_ps 65 years; Yes
Rotavirus 2, 4 months; Yes
Td 15 years (x2); Yes pregnant women
Varicella 1 year; Yes
YF 1 year; Yes

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  No  Yes 
What years does the MYP cover? number 2010-2016  2'015  2011 -2016  2011-2015  4 years     
Nº of districts with microplans that include activities to raise immunization coverage number   76  24  80  24  170 

System performance

Total Nº districts in country number 221  223  220  171  170  210  170 
Nº districts with DTP3 coverage >=80% number 115  151  142  146  151  135 
% of districts with DTP3 coverage >=80% From 0 to 100% 52  68  83  86  72  79 
Nº districts with measles (MCV1) coverage >=95% number 47  95  NA  66  112  116  80 
% of districts with MCV1 coverage >=95% From 0 to 100% 21  43    39  66  55  47 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100%   100  100  100  100  100  100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes     

Sources

 1  "The 2015 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.